623 results on '"Sirachainan, Nongnuch"'
Search Results
52. Normalized levels of red blood cells expressing phosphatidylserine, their microparticles, and activated platelets in young patients with β-thalassemia following bone marrow transplantation
53. A molecular study on the role of alpha-hemoglobin-stabilizing protein in hemoglobin H disease
54. Reported outcomes of children with newly diagnosed high-grade gliomas treated with nimotuzumab and irinotecan
55. Global Fibrinolytic Activity, PAI-1 Level, and 4G/5G Polymorphism in Thai Children with Arterial Ischemic Stroke
56. Response to Prolonged Duration of Therapeutic Dose Oral Iron Therapy in a Girl With Novel TMPRSS6 Gene Variants: A Case Report and Review Literature
57. Three-Decade Successive Establishment of Care for Women/Girls from Families with Haemophilia
58. Iliopsoas haemorrhage complicated by femoral neuropathy in patients with haemophilia: a case series report
59. Establishment of human induced pluripotent stem cell line MURAi001-A from skin fibroblasts of a patient carrying a c.4404A > G mutation in the TET1 gene
60. Construction of Antibody Library and Production of Polyclonal Antibodies Specific to Human Protein C.
61. Thalassemia and the hypercoagulable state
62. Whole‐exome sequencing uncovered genetic diagnosis of severe inherited haemolytic anaemia: Correlation with clinical phenotypes
63. Pediatric standardized bleeding assessment tool for screening bleeding disorder in school-age children
64. Identification of Alpha Thalassemia, RNF 213 p.R4810K and PROC p.R189W among Children with Moyamoya Disease/Syndrome
65. Prominent Mutation of Intron 22 Inversion in Sporadic Hemophilia: Is It Worth the Antenatal Screening?
66. Three-Decade Successive Establishment of Care for Women/Girls from Families with Haemophilia
67. Prominent Mutation of Intron 22 Inversion in Sporadic Hemophilia: Is It Worth the Antenatal Screening?
68. Effect of Iron Chelation Therapy on Glucose Metabolism in Non-Transfusion-Dependent Thalassaemia
69. Effective T‐cell replete haploidentical stem cell transplantation for pediatric patients with high‐risk hematologic disorders.
70. Normalized coagulation markers and anticoagulation proteins in children with severe β-thalassemia disease after stem cell transplantation
71. sj-docx-1-icr-10.1177_11795476221132283 – Supplemental material for Enterovirus 71-Induced Autoimmune Hemolytic Anemia in a Boy
72. Lipoprotein(a) and the risk of thromboembolism in Thai children
73. Direct transfer of data of people with haemophilia from the Thai Haemophilia Treatment Centre Registry to the World Bleeding Disorders Registry of the World Federation of Hemophilia
74. Enterovirus 71-Induced Autoimmune Hemolytic Anemia in a Boy
75. Report on effective treatment and genetic predisposition in two children with refractory probable catastrophic antiphospholipid syndrome
76. Effectiveness of Monthly Low-Dose Emicizumab Prophylaxis without 4-Week Loading Doses Among Patients with Hemophilia a with and without Inhibitor: A Case Series Report
77. Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study
78. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity
79. Effectiveness of monthly low dose emicizumab prophylaxis without 4‐week loading doses among patients with haemophilia A with and without inhibitors: A case series report.
80. The Use of Hematocrit Level for Predicting the Efficiency of Peripheral Blood CD34+ Cell Collection After G-CSF Mobilization in Healthy Donors
81. The first two cases of MYH9 disorders in Thailand: an international collaborative study
82. Report of clinical presentations and two novel mutations in patients with Wiskott-Aldrich syndrome/X-linked Thrombocytopenia
83. Intracardiac thrombus in a patient with catastrophic antiphospholipid syndrome: an autopsy case report and review of the literature
84. Combined Chelation Therapy with Daily Oral Deferiprone and Twice-Weekly Subcutaneous Infusion of Desferrioxamine in Children with β-Thalassemia: 3-Year Experience
85. Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review
86. Effect of Iron Supplementation in Children with Attention-Deficit/Hyperactivity Disorder and Iron Deficiency
87. Benefits of prophylactic emicizumab in enhancing immune tolerance induction in a boy with hemophilia A and very high inhibitor titer
88. International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis
89. Consensus‐based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID‐19–related illness
90. Response to Prolonged Duration of Therapeutic Dose Oral Iron Therapy in a Girl With Novel TMPRSS6Gene Variants: A Case Report and Review Literature
91. Report of clinical presentations and two novel mutations in patients with Wiskott-Aldrich syndrome/X-linked Thrombocytopenia.
92. International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis
93. Intramuscular anti-D in chronic immune thrombocytopenia children with severe thrombocytopenia
94. High Prevalence of Antiphospholipid Antibodies in Children with Non-Transfusion Dependent Thalassemia and Possible Correlations with Microparticles
95. Novel SOX10 Mutations in Waardenburg Syndrome: Functional Characterization and Genotype-Phenotype Analysis
96. RARE-38. CLINICAL PRESENTATION OF MGA-NUTM1 FUSION TRANSCRIPT SARCOMA
97. LGG-06. LONG-TERM OUTCOME OF NEWLY DIAGNOSED LOW GRADE GLIOMA
98. Severity Scoring System to Predict the Necessity of Regular Transfusion among Patients with Hemoglobin H
99. Consensus‐based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID‐19–related illness
100. 383 - Haploidentical Transplantation in Severe Thalassemia Patients Using Pre-Transplant Immunosuppression (PTIS) and Post-Transplant Cyclophosphamide
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.